Diphen and Cubicin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Cubicin (daptomycin). Common drug interactions include disseminated intravascular coagulation among females and chills among males.
The phase IV clinical study analyzes what interactions people have when they take Diphen and Cubicin. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.
What is Diphen?
Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.
What is Cubicin?
Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,991 Cubicin users. Check the latest studies of Cubicin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
65 people who take Diphen and Cubicin together, and have interactions are studied.

What are the common drug interactions of Diphen and Cubicin, by gender? *:
female:
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Drug toxicity
- Fatigue (feeling of tiredness)
- Glucose urine present
- Hepatic congestion (liver congestion)
- Hepatic failure (liver failure)
- Hypotension (abnormally low blood pressure)
- Ill-defined disorder
- Influenza
- International normalised ratio increased
male:
- Chills (felling of cold)
- Aortic valve disease
- Disease recurrence
- Drug ineffective
- Endocarditis (inflammation in heart muscle)
- Enterococcal infection
- Pancreatitis (inflammation of pancreas)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Renal failure (kidney dysfunction)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
What are the common drug interactions of Diphen and Cubicin, by age (0-1 to 60+)? *:
0-1:
- Meningitis enterococcal (fungal inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
2-9:
n/a
10-19:
- Agitation (state of anxiety or nervous excitement)
- Anaphylactic reaction (serious allergic reaction)
- Blood calcium decreased
- Blood glucose increased
- Brain death
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Confusional state
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Drug toxicity
20-29:
- International normalised ratio increased
30-39:
- Aortic valve disease
- Cardiac failure congestive
- Cardiac valve disease (heart valve disease)
- Cerebral artery embolism (sudden blocking of an artery by a clot or foreign material)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Coma (state of unconsciousness lasting more than six hours)
- International normalised ratio increased
- Kidney transplant rejection
- Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
- Post procedural complication
40-49:
- Swelling face
- Visual acuity reduced (reduced clearness of vision)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
- Erythema (redness of the skin)
- Haematocrit decreased
- Haemoglobin decreased
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
50-59:
- Respiratory tract infection
- Chills (felling of cold)
- Influenza
- International normalised ratio increased
- Polyarthritis (arthritis which involves 5 or more joints simultaneously)
- Rash
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Sinusitis (inflammation of sinus)
- Fall
- Muscle strain (an injury to a muscle in which the muscle fibres tear)
60+:
- Blood creatinine increased
- Aortic valve disease
- Pancreatitis (inflammation of pancreas)
- Pyrexia (fever)
- Renal impairment (severely reduced kidney function)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Blood bilirubin increased
- Blood creatine phosphokinase increased
- Blood urea increased
- Bone marrow failure
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 18 people, 27.69%
- Nausea (feeling of having an urge to vomit): 10 people, 15.38%
- Rashes (redness): 7 people, 10.77%
- Oedema (fluid collection in tissue): 6 people, 9.23%
- Proctalgia (pain in the rectum): 6 people, 9.23%
- Osteomyelitis (infection of bone): 6 people, 9.23%
- Febrile Neutropenia (fever with reduced white blood cells): 5 people, 7.69%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 5 people, 7.69%
- Hypokalemia (low potassium): 5 people, 7.69%
- Irritable Bowel Syndrome: 5 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Diphen and Cubicin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Diphen and Cubicin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Diphen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cubicin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Diphen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cubicin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on diphenhydramine hydrochloride and daptomycin (the active ingredients of Diphen and Cubicin, respectively), and Diphen and Cubicin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Novolog and Aranesp drug interactions for men aged 60+ - 6 seconds ago
- Could Ampyra cause Brain Neoplasm? - 8 seconds ago
- Repaglinide vs. Metformin, side effect and effectiveness comparison - 21 seconds ago
- Could Rozlytrek cause Hypotension? - 26 seconds ago
- Could Zyrtec cause Metamorphopsia? - 34 seconds ago
- Renal Mass and drugs of ingredients of sunitinib malate - 34 seconds ago
- Could Imuran cause Rales? - 34 seconds ago
- Allopurinol and Potassium drug interactions for women aged 40-49 - 34 seconds ago
- Foot Ulcer and drugs of ingredients of droperidol - 38 seconds ago
- Drug interactions of Glucophage Xr and Pantoprazole Sodium - 45 seconds ago